Xtandi is a medication available in the form of a capsule. It is intended in the treatment of prostate cancer in men. It is composed of the main active ingredient Enzalutamide. One of the growing pharmaceutical company, Astellas Pharma US, Inc. It is offered in a dosage of 40 mg.
Manufacturer: Astellas Pharma US, Inc.
Active Ingredient: The active ingredient is Enzalutamide, which is a bioavailable, organic, non-steroidal small molecule that targets the androgen receptor with potential antineoplastic activity. This component inhibits the activity of prostate cancer cell ARs, result in a reduction in prostate cancer cell proliferation. Reduction in the serum prostate-specific antigen level. This component is a nonsteroidal antiandrogen indicated for the treatment of metastatic castration-resistant prostate cancer.
Indications: popular brand medicine is approved for the treatment of men with a certain type of prostate cancer. This type of prostate cancer did not respond to other medicines to lower the male hormone testosterone. It is an anti-androgen i.e. anti-testosterone. Xtandi blocks the effects of testosterone to slow the growth and spread of prostate cancer.
Action Mechanism: The medicine is an androgen receptor inhibitor that includes testosterone. This type of medicine interferes with the connection between androgens and androgen receptors. Xtandi can help slow cancer cell growth.
Dosages: This effective medicine is available in the form of capsules for oral consumption. It is offered in 40 mg dosage mentioned below:
- 40 mg: Consume this medicine with or without food as directed by the doctor, usually once daily. Swallow the capsules whole. Do not chew, dissolve, or open the capsules
Note: This medicine can be absorbed through the skin and lungs and may harm an unborn baby. Pregnant women should not handle this medication or breathe the dust from the capsules.